Medication Review: Basiliximab (Simulect®): Simplifying Induction Therapy

Medication Review: Basiliximab (Simulect®): Simplifying Induction Therapy


Identification: nnj_ma00D5
Issue: March-April 2000
Volume: Vol. 27, No. 2

Standard: $30.00

Description

This article is available to members for free.

Acknowledgment: The authors wish to acknowledge Eric Adamson and Cathy M. Strizzi, Novartis Transplant Specialists, for their assistance with this article.

Author(s)

Credits

Credits: None available.

You must be logged in and own this product in order to post comments.